{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:09:45Z","timestamp":1790636985040,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0101978","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T22:40:36Z","timestamp":1406932836000},"page":"e101978","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":52,"title":["Effects of Poly-Bioactive Compounds on Lipid Profile and Body Weight in a Moderately Hypercholesterolemic Population with Low Cardiovascular Disease Risk: A Multicenter Randomized Trial"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct01562080","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Rosa","family":"Sol\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa-M","family":"Valls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Puzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Ram\u00f3n","family":"Calabuig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Brea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pedret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mori\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Anguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,1]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Media centre. Cardiovascular diseases (CVDs) (2012). Fact sheet N\u00b0317 September. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/index.html#\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/index.html#<\/ext-link> (accessed 28 January 2013)."},{"key":"ref2","first-page":"1296","article-title":"American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; Preventive Cardiovascular Nurses Association. AHA\/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation\/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association:endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women&apos;s Health Research","volume":"120(13)","author":"RF Redberg","year":"2009","journal-title":"Circulation"},{"key":"ref3","first-page":"1769","article-title":"European Heart Journal","volume":"2","author":"dyslipidaemias ESC\/EAS Guidelines for the management of","year":"2011"},{"key":"ref4","first-page":"1635","article-title":"European Heart Journal","volume":"33","year":"2012"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the trial report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"JI Cleeman","year":"2001","journal-title":"JAMA"},{"key":"ref6","article-title":"2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","author":"NJ Stone","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref7","article-title":"Statin myotoxicity: A review of genetic susceptibility factors","author":"M Needham","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/HJR.0b013e32832f3a76","article-title":"Food and vessels: the importance of a healthy diet to prevent cardiovascular disease","volume":"17(1)","author":"P Engelfriet","year":"2010","journal-title":"Eur J Cardiov Prev Rehabil"},{"key":"ref9","unstructured":"U.S. Food and Drug Administration (FDA) (2010) Dietary Supplements. Version current 6 March. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/AboutFDA\/Transparency\/Basics\/ucm193949.htm\" xlink:type=\"simple\">http:\/\/www.fda.gov\/AboutFDA\/Transparency\/Basics\/ucm193949.htm<\/ext-link> (accessed 28 January 2013)."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ctim.2005.07.008","article-title":"Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: a pilot study","volume":"13","author":"AFG Cicero","year":"2005","journal-title":"Complem Ther Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12349-010-0028-5","article-title":"Efficacy of a red yeast rice based nutraceutical in large subgroups of hypercholesterolemic subjects in every day clinical practice","volume":"3","author":"AFG Cicero","year":"2010","journal-title":"Med J Nutr Metab"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12349-010-0043-6","article-title":"Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet","volume":"4(2)","author":"B Trimarco","year":"2011","journal-title":"Med J Nutrition Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1067\/mhj.2002.119997","article-title":"Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent","volume":"143(2)","author":"I Gouni-Berthold","year":"2002","journal-title":"Am Heart J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1592\/phco.25.2.171.56942","article-title":"Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol","volume":"(2)","author":"JT Chen","year":"2005","journal-title":"Pharmacotherapy; 25"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/ajcn\/84.6.1543","article-title":"Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial","volume":"84(6)","author":"MF Dulin","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.295.19.2262","article-title":"Effect of Policosanol on Lipid Levels Among Patients With Hypercholesterolemia or Combined Hyperlipidemia","volume":"295(19)","author":"HK Berthold","year":"2006","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.nutres.2013.05.015","article-title":"Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects","volume":"33(8)","author":"AFG Cicero","year":"2013","journal-title":"Nutr Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ctim.2012.07.004","article-title":"The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders","volume":"20(6)","author":"CW Yang","year":"2012","journal-title":"Complement Ther Med"},{"key":"ref19","first-page":"355","article-title":"Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential","volume":"16(4)","author":"P Kidd","year":"2011","journal-title":"Altern Med Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcn\/82.4.806","article-title":"Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials","volume":"82(4)","author":"Collaboration Homocysteine Lowering Trialists'","year":"2005","journal-title":"Am J Clin Nut"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.phymed.2012.05.009","article-title":"Lipid-lowering effect of berberine in human subjects and rats","volume":"19(10)","author":"Y Hu","year":"2012","journal-title":"Phytomedicine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4330\/wjc.v4.i3.77","article-title":"A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome","volume":"4(3)","author":"F Affuso","year":"2012","journal-title":"World J Cardiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1476-511X-11-123","article-title":"Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment","volume":"11","author":"L Pisciotta","year":"2012","journal-title":"Lipids Health Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/HJH.0b013e3283395208","article-title":"Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia","volume":"28(7)","author":"R Izzo","year":"2010","journal-title":"J Hypertens"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.numecd.2009.10.015","article-title":"The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols","volume":"21(6)","author":"O Guardamagna","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation","volume":"18","author":"WT Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"DR Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S0954422412000170","article-title":"Food combinations for cholesterol lowering","volume":"25(2)","author":"JI Harland","year":"2012","journal-title":"Nutr Res Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/db06-0006","article-title":"Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states","volume":"55(8)","author":"YS Lee","year":"2006","journal-title":"Diabetes"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e24520","DOI":"10.1371\/journal.pone.0024520","article-title":"Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL\/6J Mice","volume":"6(9)","author":"W Xie","year":"2011","journal-title":"PLoS ONE"},{"key":"ref31","first-page":"26","article-title":"Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents","volume":"57(1)","author":"AFG Cicero","year":"2007","journal-title":"Arzneimittel-Forschung (Drug Research)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s12325-011-0082-5","article-title":"Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients","volume":"28(12)","author":"G Marazzi","year":"2011","journal-title":"Adv Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/jama.1986.03380200073024","article-title":"Incidence of coronary heart disease and lipoprotein cholesterol levels, The Framingham Study","volume":"256","author":"WP Castelli","year":"1986","journal-title":"JAMA"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jama.294.3.326","article-title":"Non-HDL cholesterol, apolipoprotein A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women","volume":"294","author":"PM Ridker","year":"2005","journal-title":"JAMA"},{"key":"ref35","unstructured":"American Heart Association (2013) Version current February 2013. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.heart.org\/HEARTORG\/Conditions\/Cholesterol\/AboutCholesterol\/What-Your-Cholesterol-Levels-Mean_UCM_305562_Article.jsp\" xlink:type=\"simple\">http:\/\/www.heart.org\/HEARTORG\/Conditions\/Cholesterol\/AboutCholesterol\/What-Your-Cholesterol-Levels-Mean_UCM_305562_Article.jsp<\/ext-link> (accessed 22 February 2013)."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(08)61076-4","article-title":"Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study","volume":"(9634)","author":"MJ McQueen","year":"2008","journal-title":"Lancet 372"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/eurheartj\/ehp221","article-title":"The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls","volume":"30(17)","author":"S Parish","year":"2009","journal-title":"Eur Heart J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2796.2005.01610.x","article-title":"Stroke mortality and the apoB\/apoA-I ratio: results of the AMORIS prospective study","volume":"259","author":"G Walldius","year":"2006","journal-title":"J Intern Med"},{"key":"ref39","first-page":"159","article-title":"A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia","volume":"15(4)","author":"M Canetti","year":"1995","journal-title":"Int J Clin Pharmacol Res"},{"key":"ref40","first-page":"1101","article-title":"Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry","volume":"35(5)","author":"YG Li","year":"2004","journal-title":"J Pharm Biomed Anal 2004"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1043-4526(07)53004-4","article-title":"Monascus rice products","volume":"53","author":"TH Wang","year":"2007","journal-title":"Adv Food Nutr Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.amjcard.2008.02.056","article-title":"Chinese Coronary Secondary Prevention Study Group, Li S. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction","volume":"101(12)","author":"Z Lu","year":"2008","journal-title":"Am J Cardiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"(12)","author":"W Kong","year":"2004","journal-title":"Nature Medicine 10"},{"key":"ref44","first-page":"337","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes","volume":"4(3)","author":"AD Sniderman","year":"2011","journal-title":"2011"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0101978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T21:20:13Z","timestamp":1598131213000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0101978"}},"subtitle":[],"editor":[{"given":"Alberico","family":"Catapano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0101978","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,1]]}}}